Physician profile
Philip S Fox
NPI 1013976596
$496.81
in general payments reported to CMS, 2019-2025
10 companies · $79.50 in 2025
The $79.50 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $220 · 2025: $79.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $79.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $79.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $161.55 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $79.50 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.72 | 2019 | |
| Lundbeck LLC | $45.86 | 2019-2020 | |
| Allergan, INC. | $43.29 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $41.34 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $33.49 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $16.38 | 2019 | |
| Shire North American Group INC | $13.60 | 2019 | |
| Vanda Pharmaceuticals INC. | $11.08 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.